BANK VONTOBEL/CALL/CVS HEALTH/82/0.1/20.09.24 Share Price

Warrant

DE000VM3MBA5

Market Closed - Deutsche Boerse AG 18:50:40 10/05/2024 BST
0.015 EUR +50.00% Intraday chart for BANK VONTOBEL/CALL/CVS HEALTH/82/0.1/20.09.24
Current month-74.58%
1 month-86.96%
Date Price Change Volume
10/05/24 0.015 +50.00% 0
09/05/24 0.01 0.00% 0
08/05/24 0.01 -9.09% 0
07/05/24 0.011 +10.00% 0
06/05/24 0.01 -23.08% 0

Delayed Quote Deutsche Boerse AG

Last update May 10, 2024 at 06:50 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying CVS HEALTH CORPORATION
IssuerLogo Issuer Vontobel Vontobel
WKN VM3MBA
ISINDE000VM3MBA5
Date issued 06/10/2023
Strike 82 $
Maturity 20/09/2024 (133 Days)
Parity 10 : 1
Emission price 0.33
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.72
Lowest since issue 0.01
Spread 0.01
Spread %47.62%

Company Profile

CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows: - medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.; - retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®); - medical benefits management (25.8%); - other (0.1%).
Sector
-
More about the company

Ratings for CVS Health Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: CVS Health Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
55.82 USD
Average target price
71.37 USD
Spread / Average Target
+27.86%
Consensus